Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiarrhythmic and antiremodeling effects of ivabradine in ICD carriers
2012-003034-16Phase 4Terminated
- Sponsor
- University Hospital Olomouc
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine in heart failure (HF) and ventricular arrhythmia (VA), sponsored by University Hospital Olomouc. Primary endpoint: Decrease in arrhythmia incidence in the group treated with ivabradine. Started Jun 2013; status: terminated.
02
Drugs
ivabradine
03
Conditions
heart failure (HF)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on 2012-003034-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003034-16.